IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IRADIMED CORPORATION on October 30, 2014. The filing serves to announce the Company's financial results for the third quarter ended September 30, 2014. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the body of this 8-K document.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative financial analysis.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The document explicitly states that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Facts for Investor Verification
- Verify the specific revenue and net income figures for the third quarter ended September 30, 2014, in the attached press release (Exhibit 99.1).
- Confirm year-over-year growth rates and margin trends as detailed in the press release.
- Review the press release for any updated full-year guidance or management commentary on market conditions.
- Note that the financial data in this filing is not deemed "filed" under Section 18 of the Exchange Act.